IL-20, an anti-angiogenic cytokine that inhibits COX-2 expression.
暂无分享,去创建一个
J. Minna | J. Shay | L. Goodglick | R. Strieter | Li Zhu | R. Ramirez | S. Dubinett | Ming Liu | N. Heuzé-Vourc’h | Sherven Sharma | H. Dalwadi | Felicita E. Baratelli | M. Põld | Sherven P Sharma
[1] J. Pollack,et al. Immortalization of Human Bronchial Epithelial Cells in the Absence of Viral Oncoproteins , 2004, Cancer Research.
[2] Y. Surh,et al. Signal transduction pathways regulating cyclooxygenase-2 expression: potential molecular targets for chemoprevention. , 2004, Biochemical pharmacology.
[3] R. Strieter,et al. Multifaceted roles of cyclooxygenase-2 in lung cancer. , 2004, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.
[4] M. Burdick,et al. Cyclooxygenase-2 dependent expression of angiogenic CXC chemokines, ENA-78/CXCL5 and IL-8/CXCL8, in human non-small cell lung cancer , 2004 .
[5] C. D. Krause,et al. Interleukin-10 and related cytokines and receptors. , 2004, Annual review of immunology.
[6] M. Burdick,et al. Cyclooxygenase-2-Dependent Expression of Angiogenic CXC Chemokines ENA-78/CXC Ligand (CXCL) 5 and Interleukin-8/CXCL8 in Human Non-Small Cell Lung Cancer , 2004, Cancer Research.
[7] S. Gately. The Contributions of Cyclooxygenase-2 to Tumor Angiogenesis , 2004, Cancer and Metastasis Reviews.
[8] K. Subbaramaiah,et al. Targeting cyclooxygenase-2 in human neoplasia: rationale and promise. , 2003, Cancer cell.
[9] H. Broxmeyer,et al. Selective enhancement of multipotential hematopoietic progenitors in vitro and in vivo by IL-20. , 2003, Blood.
[10] J. Castelao,et al. Lung cancer and cyclooxygenase-2. , 2003, The Annals of thoracic surgery.
[11] J. Talley,et al. Cyclooxygenase 2 (COX-2) as a target for therapy and noninvasive imaging. , 2003, Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging.
[12] A. Koch,et al. The role of COX-2 in angiogenesis and rheumatoid arthritis. , 2003, Experimental and molecular pathology.
[13] Li Zhu,et al. Abnormal Interleukin 10Rα Expression Contributes to the Maintenance of Elevated Cyclooxygenase-2 in Non-Small Cell Lung Cancer Cells , 2003 .
[14] S. Pestka,et al. MDA-7/IL-24: novel cancer growth suppressing and apoptosis inducing cytokine. , 2003, Cytokine & growth factor reviews.
[15] K. Subbaramaiah,et al. Cyclooxygenase 2: a molecular target for cancer prevention and treatment. , 2003, Trends in pharmacological sciences.
[16] K. Madden,et al. Interleukins 19, 20, and 24 Signal through Two Distinct Receptor Complexes , 2002, The Journal of Biological Chemistry.
[17] K. Subbaramaiah,et al. Cyclooxygenase-2: a target for the prevention and treatment of breast cancer. , 2001, Endocrine-related cancer.
[18] D. Conklin,et al. Interleukin 20 Discovery, Receptor Identification, and Role in Epidermal Function , 2001, Cell.
[19] R. Coffman,et al. Interleukin-10 and the interleukin-10 receptor. , 2001, Annual review of immunology.
[20] R. DuBois,et al. Cyclooxygenase Regulates Angiogenesis Induced by Colon Cancer Cells , 1998, Cell.
[21] Li Zhu,et al. Non-small cell lung cancer cyclooxygenase-2-dependent regulation of cytokine balance in lymphocytes and macrophages: up-regulation of interleukin 10 and down-regulation of interleukin 12 production. , 1998, Cancer research.
[22] S. Dubinett,et al. Human Non-Small Cell Lung Cancer Cells Express a Type 2 Cytokine Pattern 1 , 2006 .